Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
- PMID: 9720972
- DOI: 10.1007/s007020050068
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
Abstract
The search for the causes of neurodegenerative disorders is a major theme in brain research. Acquired disturbances of several aspects of cellular metabolism appear pathologically important in sporadic Alzheimer's disease (SDAT). Among these brain glucose utilisation is reduced in the early stages of the disease and the regulatory enzymes important for glucose metabolism are reduced. In the brain, insulin, insulin-like growth factors and their receptors regulate glucose metabolism and promote neuronal growth. To detect changes in the functional activity of the brain insulin neuromodulatory system of SDAT patients, we determined the concentrations of insulin and c-peptide as well as insulin receptor binding and IGF-I receptor binding in several regions of postmortem brain cortex during aging and Alzheimer's disease. Additionally, we performed immunohistochemical staining with antibodies against insulin in neocortical brain areas in SDAT and controls. We show for the first time that insulin and c-peptide concentration in the brain are correlated and decrease with aging, as do brain insulin receptor densities. Weak insulin-immunoreactivity could be demonstrated histochemically in pyramidal neurons of controls, whereas in SDAT a stronger insulin-immunoreactivity was found. On a biochemical level, insulin and c-peptide levels were reduced compared to middle-aged controls, but were unchanged compared to age-matched controls. Brain insulin receptor densities in SDAT were decreased compared to middle-aged controls, but increased in comparison to age-matched controls. IGF-I receptor densities were unchanged in aging and in SDAT. Tyrosine kinase activity, a signal transduction mechanism common to both receptor systems, was reduced in SDAT in comparison to middle-aged and age-matched control groups. These data are consistent with a neurotrophic role of insulin in the human brain and a disturbance of insulin signal transduction in SDAT brain and favor the hypothesis that insulin dependent functions may be of pathogenetic relevance in sporadic SDAT.
Similar articles
-
A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease.Ann N Y Acad Sci. 1999;893:290-3. doi: 10.1111/j.1749-6632.1999.tb07839.x. Ann N Y Acad Sci. 1999. PMID: 10672251
-
Orthostatic hypotension in Alzheimer's disease: result or cause of brain dysfunction?Aging (Milano). 1999 Jun;11(3):155-60. Aging (Milano). 1999. PMID: 10476310
-
Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease.J Gerontol A Biol Sci Med Sci. 1995 Sep;50(5):B315-9. doi: 10.1093/gerona/50a.5.b315. J Gerontol A Biol Sci Med Sci. 1995. PMID: 7545530
-
Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism.J Neural Transm Suppl. 1998;54:187-94. doi: 10.1007/978-3-7091-7508-8_18. J Neural Transm Suppl. 1998. PMID: 9850927 Review.
-
Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease.Acta Neurol Scand Suppl. 1996;165:18-24. doi: 10.1111/j.1600-0404.1996.tb05868.x. Acta Neurol Scand Suppl. 1996. PMID: 8740985 Review.
Cited by
-
Aberrant insulin signaling in Alzheimer's disease: current knowledge.Front Neurosci. 2015 Jun 16;9:204. doi: 10.3389/fnins.2015.00204. eCollection 2015. Front Neurosci. 2015. PMID: 26136647 Free PMC article. Review.
-
Hyperinsulinemia in rats causes impairment of spatial memory and learning with defects in hippocampal synaptic plasticity by involvement of postsynaptic mechanisms.Exp Brain Res. 2013 Apr;226(1):45-51. doi: 10.1007/s00221-013-3409-4. Epub 2013 Feb 1. Exp Brain Res. 2013. PMID: 23371746
-
ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing Aβ impairment of insulin signaling in an Alzheimer's disease mouse model.Sci Rep. 2016 May 18;6:26119. doi: 10.1038/srep26119. Sci Rep. 2016. PMID: 27189808 Free PMC article.
-
Potential biomarkers of Alzheimer's disease and cerebral small vessel disease.Front Mol Neurosci. 2022 Oct 10;15:996107. doi: 10.3389/fnmol.2022.996107. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36299860 Free PMC article.
-
The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease.Int J Biol Sci. 2022 Jan 1;18(3):983-994. doi: 10.7150/ijbs.66871. eCollection 2022. Int J Biol Sci. 2022. PMID: 35173531 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical